'"Genome to Drug" (Dhanvantari) envisages delivering a drug molecule to society from genomic / proteomic information.
It consists of mainly three stages:
(1) interpreting the language of genomic DNA and identifying a druggable protein coding gene (Chemgenome) for a disease / disorder,
(2)
determining the three dimensional structure of the protein target (
Bhageerath) and
(3) creating a small molecule (drug) that can bind with
high affinity and specificity to the Protein/DNA target but with least toxicity to
humans (Sanjeevini).
Read more at (SCFBio Presentation 2013 Version).
To develop novel scientific methods and highly efficient algorithms, combining principles of Chemistry and Biology with Information Technology for Genome analysis, Protein structure prediction and target directed Drug Design pursuing the dream of delivering GENOME to DRUG to the society.[Reference]
The facility is committed towards providing free access of its bioinformatics and computational biology tools to the global user community.
ChemGenome:Chemgenome identifies protein coding / regulatory regions
from genomic information based on the physico-chemical principles
behind genome organization.
Genome Analysis Software Suite
http://pubs.acs.org/doi/abs/10.1021/ja3020956
Bhageerath H:Bhageerath-H has currently
reached 60% accuracy in predicting 3D structures of soluble proteins to
within 5Ang from the native in the absence of experimental structures.
A Homology ab-intio Hybrid Web server
for Protein Tertiary Structure Prediction
DOI: 10.1002/jcc.23339
DOI:10.1016/j.bbapap.2013.04.023
Sanjeevini:Sanjeevini helps to create lead compounds (drugs) targeted to
Protein/DNA. Sanjeevini has been
able to generate a few sub-micromolar compounds against malaria & breast
cancer.These are under further development
In-Silico Drug Design Software
http://www.biomedcentral.com/1471-2105/13/S17/S7
A plausible mechanism for the antimalarial activity of artemisinin: A computational approach . Ashutosh Shandilya, Sajeev Chacko, B. Jayaram & Indira Ghosh.Scientific Reports 3, Article number: 2513 DOI:10.1038/srep02513.